Wedbush maintains Ascendis Pharma price target at $327
Wedbush maintained a $327.00/share price target for Ascendis Pharma.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.